Putting People
at the Center
of Business

HundredX serves as the premier source of truth for leaders and investors about the experiences of everyday customers

Powered by best-in-class insights from ethically sourced data, HundredX is reshaping business leadership, strategy development, and investing

  • Slide title

    Write your caption here
    Button
The HundredX Breakthrough


Founded in 2012 to help leaders and investors become better at listening to customers, HundredX developed a breakthrough linkage between customer experience and future performance, unlocking a new era in how businesses are managed and evaluated.

A black and white photo of a group of people standing around a table.
A cell phone with hundredx written on the screen
Powered by “Data-for-Good"


The HundredX innovative "data for good" model provides funding to nonprofits and other cause-based organizations for every piece of qualifying feedback from their supporters. Unlike traditional surveys, participants select the brands they use and share whether and why they expect to buy more or less in the future.


Our model has produced more than 17 million pieces of feedback from actual customers across 4,000+ brands. To date, HundredX has provided more than $27 million to more than 2,500 highly diverse organizations through its HundredX Causes™ programs.



Driving the Future of Strategy & Investing

Executives of leading enterprises rely on HundredX data to spot key trends and inflections and drive their growth strategies. Investors value HundredX data because its unique and predictive nature informs their strategies to outperform benchmarks.

A group of people are standing around a table with boxes and bags.

Core Tenants of our Vision

A shopping cart icon in a blue square on a white background.

Listening Versus Surveying

We allow customers to select which brands to evaluate and to choose what matters most and why, delivering highly relevant and actionable insights.

A computer monitor icon in a blue square on a white background.

Connect to the Real World

We harness the power of listening and the genius of the crowd to deliver insights that are more predictive of future trends and performance.

A shopping cart icon in a blue square on a white background.

Diverse Voices

We believe everyone’s voice should be heard and elevate the diverse voices of real, everyday customers across all demographics.

A computer monitor icon in a blue square on a white background.

Data for Good

We use ethically sourced, double-blind customer experience data through a groundbreaking model that benefits charities and other causes.

Multiplying Positive Outcomes

As an entrepreneurial, mission-based company, our core focus is creating a positive impact on people, businesses, and society. We aim to enhance consumer experiences and drive market share growth for businesses, all while channeling critical funding towards nonprofit organizations.


Guided by our cultural values of excellence, kindness, and client-centricity, we're inspired by the belief that we can turn everyday voices into impact and make a difference in the world.

Join Our Team

Featured insights from The Crowd Report™

View All
A stack of coins with the words consumer spending muted amid rising prices

Consumer spending muted amid rising prices

November 7, 2024
Consumers are navigating still-high prices with resilience. HundredX analysis, based on millions of pieces of customer feedback from July 2021 through April 2023 across 3,200+ companies, indicates inflation remains persistent, but consumers are cautiously hanging on. New Consumer Price Index (CPI) data shows prices increased 3.4% in April from a year ago, compared to 3.5% in March, which highlights a slight easing in inflation month-to-month. Still, HundredX data shows that consumers still feel negative about prices in general, pointing to inflation’s stickiness and consumer frustrations over the consistently high prices of everyday goods. Generally, we’ve seen that changes to HundredX’s Price favorability index are typically inversely correlated with movement in the CPI levels (i.e., inflation) reported by the US government.
Starbucks shows weakness as consumers feel inflation fatigue

Starbucks shows weakness as consumers feel worse about taste

May 6, 2024
Sure, lattes, mochaccinos, and cappuccinos are pricey, but they taste delicious. For many consumers, the great taste of coffee shop coffee made it worth the cost. But customers at Starbucks aren't so sure the tradeoff is worth it anymore. Examining more than 420,000 pieces of feedback across the Quick, Fast, Casual (QFC) industry, including over 21,000 on Starbucks, we find: Starbuck's Purchase Intent 1,2 is down 3% over the past six months, with most of that dip occurring over the past few months. By contrast, Dunkin' Donuts has remained within a tight range over the past six months, as did an average of other, smaller coffee chains. Customers increasingly see less value in Starbucks. Starbuck's Value perception 3 fell 5% over the past six months, compared to just 1% for Dunkin' Donuts. However, it also fell 5% for the average of the smaller coffee chains. Coffee drinkers feel significantly unhappier about Starbuck's quality and taste. Starbuck's Taste perception fell 4% over the past six months, while rising 1% for competitors. Likewise, its Quality perception dipped 3% over the same time period (and 8% over the year). Ultimately, Starbuck's perceived drop in taste is leading inflation-weary consumers to say they plan to spend less at the coffee chain, as the value just isn't as good.
A person is holding a prescription medication in their hand

Mounjaro maintains top spot among GLP-1 drugs

May 6, 2024
Ozempic once dominated the headlines, but GLP-1 competitor Mounjaro is winning over customers. GLP-1 drugs, used for treating diabetes and aiding in weight loss, are relatively new on the market yet have surged in popularity over the last year. They're becoming so popular that J.P. Morgan estimates that 30 million people in the US may be using a GLP-1 drug by 2030. This statistic presents a significant potential for early drug creator Novo Nordisk (Ozempic, Wegovy), and perhaps an even bigger one for Eli Lilly (Mounjaro, Zepbound). HundredX data indicates Eli Lilly is in a position to win over Novo Nordisk as Mounjaro's Usage Intent widens against the competition. Ozempic may have name recognition, but customers feel more positively about Mounjaro's effectiveness and lifestyle impact, even if they aren't excited about its high price. Examining 1,500 pieces of customer feedback across Mounjaro, Ozempic, and Wegovy, we find: GLP-1 users increasingly say they plan to use Mounjaro more, and Ozempic less . Mounjaro’s Usage Intent is up 19% since July, Wegovy’s is up 3%, and Ozempic has stayed within a tight range. Customers feel Mounjaro is more effective than competing drugs, but it’s harder to get . Mounjaro outperforms other GLP-1 drugs in effectiveness, lifestyle impact, and side effects. However, customers dislike its cost and availably more than competitors.